Health And Medicine

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural “endocannabinoids” without gastrointestinal side effects, Vanderbilt University scientists will report next week. Read More

A study of cognitive complaints in older adults showed that memory concerns from both the patient and an informant was most predictive of converting to Alzheimer’s disease or dementia within three years. Read More

Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups. Read More

A case series by researchers at Vanderbilt University Medical Center examines three patients transferred here with ischemic stroke who later received a diagnosis of fungal meningitis attributed to tainted injections for low back pain, part of a multi-state outbreak. Read More

Insight into how the protein neurofibromin participates in the signaling pathway that produces the body’s long bones has implications for fracture healing in some patients. Read More

A motor protein that helps drive cell division may be a promising new target for cancer therapeutics. Read More

Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks. Read More

Adults have calendar applications on all their digital devices to remind them of appointments and what’s next on their agenda. Read More

David DeGraff, Ph.D., has received the 2013 BCAN Young Investigator Award for Bladder Cancer Research. Read More

Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP). Read More

High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found. Read More

The new web application NetGestalt will allow investigators to simultaneously visualize different types of data for the same gene – such as mutation, expression and modification. Read More

Vanderbilt researchers have discovered new roles for a protein involved in cell death processes that are activated to prevent tumor-causing DNA mutations. Read More

Vanderbilt researchers propose guidelines for defining patient retention in clinical studies – an important parameter that affects study conclusions and program evaluations. Read More

Certain MRI metrics can be used to assess myelin loss in multiple sclerosis, which is important for planning and monitoring therapy. Read More

Two new “super-resolution” optical microscopes have put Vanderbilt University Medical Center on the cutting edge of cellular imaging, and are giving researchers their first views of the cell at the molecular level. Read More

The National Institutes of Health requires scientists to provide public access to any peer-reviewed publications resulting from NIH-supported research through PubMed, the National Library of Medicine’s premier search system. Read More

Nephrologist William Fissell IV, M.D., associate professor of Medicine and Biomedical Engineering, is intent on creating and mass-producing an implantable bioartificial kidney that can transform quality of life and prospects for survival for people with chronic kidney disease who would otherwise be forced onto dialysis. Read More

Children who receive a vaccine to prevent blood and ear infections may be reducing the spread of pneumonia to the rest of the population, especially their grandparents and other older adults. Read More

A zebrafish model of a severe mitochondrial disease will be useful for developing new therapeutic approaches. Read More